Neuropsychological consequences of chronic drug use: Relevance to treatment approaches

Frontiers in Psychiatry

Volumn 6, Issue JAN, 2016, Pages

  Cadet, Jean Lud ^a   Bisagno, Veronica ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Instituto de Investigaciones Farmacologicas   (Argentina)

Author keywords

Cocaine; Cognition; Frontal cortex; Marijuana; Methamphetamine

Indexed keywords

AMYGDALA; ANTERIOR CINGULATE; APATHY; ATTENTION; AWARENESS; BRAIN FUNCTION; BRAIN REGION; CANNABIS ADDICTION; CEREBELLUM; CINGULATE GYRUS; COCAINE DEPENDENCE; COGNITION; CORPUS STRIATUM; DECISION MAKING; DECLARATIVE MEMORY; DORSOMEDIAL PREFRONTAL CORTEX; EMPATHY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FRONTAL CORTEX; FRONTAL GYRUS; GLOBUS PALLIDUS; HEMISPHERIC DOMINANCE; HUMAN; HYPERPERFUSION; IMPULSIVENESS; INFORMATION PROCESSING; INSULA; INTELLIGENCE; LANGUAGE ABILITY; LEARNING; LINGUAL GYRUS; MEDIAL FRONTAL CORTEX; MESENCEPHALON; METABOLIC ACTIVATION; METHAMPHETAMINE DEPENDENCE; MOTOR CORTEX; MOTOR PERFORMANCE; NEUROPSYCHOLOGY; OCCIPITAL CORTEX; OCCIPITAL GYRUS; OCCIPITOPARIETAL CORTEX; ORBITAL CORTEX; PARAHIPPOCAMPAL GYRUS; PARIETAL CORTEX; PREFRONTAL CORTEX; PROSPECTIVE MEMORY; PSYCHOMOTOR ACTIVITY; PULVINAR; PUTAMEN; RECALL; RECOGNITION; RETROSPECTIVE MEMORY; REVIEW; REWARD; SENSORIMOTOR FUNCTION; SPATIAL MEMORY; SUPERIOR FRONTAL GYRUS; TEMPORAL GYRUS; THALAMUS; VERBAL MEMORY; VISUAL INFORMATION; VISUAL MEMORY; WORKING MEMORY;

EID: 84964682962     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00189     Document Type: Review

References (136)

1. Cadet JL, Bisagno V, Milroy CM. Neuropathology of substance use disorders. Acta Neuropathol (2014) 127:91-107. doi: 10.1007/s00401-013-1221-7.
2. Volkow ND, Wang G-J, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol (2012) 52:321-36. doi:10.1146/annurev-pharmtox-010611-134625.
3. Schulte MH, Cousijn J, den Uyl TE, Goudriaan AE, van den Brink W, Veltman DJ, et al. Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clin Psychol Rev (2014) 34:531-50. doi:10.1016/j.cpr.2014.08.002.
4. Ersche KD, Turton AJ, Chamberlain SR, Müller U, Bullmore ET, Robbins TW. Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 169:926-36. doi:10.1176/appi.ajp.2012.11091421.
5. Iudicello JE, Woods SP, Vigil O, Scott JC, Cherner M, Heaton RK, et al. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. J Clin Exp Neuropsychol (2010) 32:704-18. doi:10.1080/13803390903512637.
6. Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci (2003) 15:215-20. doi:10.1176/jnp.15.2.215.
7. Garavan H, Stout JC. Neurocognitive insights into substance abuse. Trends Cogn Sci (2005) 9:195-201. doi:10.1016/j.tics.2005.02.008.
8. Bolla KI, Rothman R, Cadet JL. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1999) 11:361-9. doi:10.1176/jnp.11.3.361.
9. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology (2002) 59:1337-43. doi:10.1212/01.WNL.0000031422.66442.49.
10. Dean AC, Groman SM, Morales AM, London ED. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology (2013) 38:259-74. doi:10.1038/npp.2012.179.
11. Weinborn M, Moyle J, Bucks RS, Stritzke W, Leighton A, Woods SP. Time-based prospective memory predicts engagement in risk behaviors among substance users: results from clinical and nonclinical samples. J Int Neuropsychol Soc (2013) 19:284-94. doi:10.1017/S1355617712001361.
12. UNODC 2013 World Drug Report. (2013). Available from: https://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf.
13. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry (2001) 58:909-15. doi:10.1001/archpsyc.58.10.909.
14. Pope HG Jr, Gruber AJ, Yurgelun-Todd D. Residual neuropsychologic effects of cannabis. Curr Psychiatry Rep (2001) 3:507-12. doi:10.1007/s11920-001-0045-7.
15. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, Ghoneim MM, et al. Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav (2002) 72:237-50. doi:10.1016/S0091-3057(01)00771-7.
16. Abdullaev Y, Posner MI, Nunnally R, Dishion TJ. Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behav Brain Res (2010) 215:45-57. doi:10.1016/j.bbr.2010.06.023.
17. Bolla KI, Eldreth D, Matochik J, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage (2005) 26:480-92. doi:10.1016/j.neuroimage.2005.02.012.
18. King GR, Ernst T, Deng W, Stenger A, Gonzales RM, Nakama H, et al. Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci (2011) 31:17923-31. doi:10.1523/JNEUROSCI.4148-11.2011.
19. Colizzi M, Fazio L, Ferranti L, Porcelli A, Masellis R, Marvulli D, et al. Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior. Neuropsychopharmacology (2015) 40:640-9. doi:10.1038/npp.2014.213.
20. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of marihuana - a comparison with pre-drug performance. Neurotoxicol Teratol (2005) 27:231-9. doi:10.1016/j.ntt.2004.11.003.
21. Solowij N, Michie PT, Fox AM. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry (1995) 37:731-9. doi:10.1016/0006-3223(94)00178-6.
22. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA (2002) 287(13):1123-31. Erratum in: JAMA (2002) 287:1651.
23. Lyons MJ, Bar JL, Panizzon MS, Toomey R, Eisen S, Xian H, et al. Neuropsychological consequences of regular marijuana use: a twin study. Psychol Med (2004) 34:1239-50. doi:10.1017/S0033291704002260.
24. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang TT, Tapert SF. Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol (2009) 14:457-68. doi:10.1111/j.1369-1600.2009.00166.x.
25. Hanson KL, Winward JL, Schweinsburg AD, Medina KL, Brown SA, Tapert SF. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict Behav (2010) 35:970-6. doi:10.1016/j.addbeh.2010.06.012.
26. Battisti RA, Roodenrys S, Johnstone SJ, Respondek C, Hermens DF, Solowij N. Chronic use of cannabis and poor neural efficiency in verbal memory ability. Psychopharmacology (2010) 209:319-30. doi:10.1007/s00213-010-1800-4.
27. Griffith-Lendering MFH, Huijbregts SCJ, Vollebergh WAM, Swaab H. Motivational and cognitive inhibitory control in recreational cannabis users. J Clin Exp Neuropsychol (2012) 34:688-97. doi:10.1080/13803395.2012.668874.
28. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A (2012) 109:E2657-64. doi:10.1073/pnas.1206820109.
29. Solowij N, Jones KA, Rozman ME, Davis SM, Ciarrochi J, Heaven PC, et al. Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology (2012) 219:575-86. doi:10.1007/s00213-011-2486-y.
30. Sewell RA, Schnakenberg A, Elander J, Radhakrishnan R, Williams A, Skosnik PD, et al. Acute effects of THC on time perception in frequent and infrequent cannabis users. Psychopharmacology (Berl) (2013) 226:401-13. doi:10.1007/s00213-012-2915-6.
31. Chang L, Yakupov R, Cloak C, Ernst T. Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain (2006) 129:1096-112. doi:10.1093/brain/awl064.
32. Padula CB, Schweinsburg AD, Tapert SF. Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychol Addict Behav (2007) 21:478-87. doi:10.1037/0893-164X.21.4.478.
33. Tapert SF, Schweinsburg AD, Drummond SPA, Paulus MP, Brown SA, Yang TT. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (2007) 194:173-83. doi:10.1007/s00213-007-0823-y.
34. Schweinsburg AD, Nagel BJ, Schweinsburg BC, Park A, Theilmann RJ, Tapert SF. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res (2008) 163:40-51. doi:10.1016/j.pscychresns.2007.04.018.
35. Hester R, Nestor L, Garavan H. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology (2009) 34:2450-8. doi:10.1038/npp.2009.67.
36. Hanlon CA, Dufault DL, Wesley MJ, Porrino LJ. Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology (2011) 218:681-92. doi:10.1007/s00213-011-2360-y.
37. Wesley MJ, Hanlon CA, Porrino LJ. Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res (2011) 191:51-9. doi:10.1016/j.pscychresns.2010.10.002.
38. Harding IH, Solowij N, Harrison BJ, Takagi M, Lorenzetti V, Lubman DI, et al. Functional connectivity in brain networks underlying cognitive control in chronic cannabis users. Neuropsychopharmacology (2012) 37:1923-33. doi:10.1038/npp.2012.39.
39. Schuster RM, Crane NA, Mermelstein R, Gonzalez R. The influence of inhibitory control and episodic memory on the risky sexual behavior of young adult cannabis users. J Int Neuropsychol Soc (2012) 18:827-33. doi:10.1016/j.biopsych.2008.
40. Bossong MG, Niesink RJM. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol (2010) 92:370-85. doi:10.1016/j.pneurobio.2010.06.010.
41. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet (2009) 374:1383-91. doi:10.1016/S0140-6736(09)61037-0.
42. Moore THM, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 370:319-28. doi:10.1016/S0140-6736(07)61162-3.
43. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P, et al. Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry (2012) 69:27-36. doi:10.1001/archgenpsychiatry.2011.161.
44. Pertwee RG. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol (2008) 13:147-59. doi:10.1111/j.1369-1600.2008.00108.x.
45. Parsons LH, Hurd YL. Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci (2015) 16:579-94. doi:10.1038/nrn4004.
46. Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: susceptibility to psychiatric illness. Front Psychiatry (2013) 4:129. doi:10.3389/fpsyt.2013.00129.
47. Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 195:488-91. doi:10.1192/bjp.bp.109.064220.
48. Morgan CJA, Curran HV. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br J Psychiatry (2008) 192:306-7. doi:10.1192/bjp.bp.107.046649.
49. McQueeny T, Padula CB, Price J, Medina KL, Logan P, Tapert SF. Gender effects on amygdala morphometry in adolescent marijuana users. Behav Brain Res (2011) 224:128-34. doi:10.1016/j.bbr.2011.05.031.
50. Colzato LS, Hommel B. Recreational use of cocaine eliminates inhibition of return. Neuropsychology (2009) 23:125-9. doi:10.1037/a0013821.
51. Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol (2012) 52:321-36. doi:10.1146/annurev-pharmtox-010611-134625.
52. Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci (1991) 7:73-9. doi:10.3109/00207459109150348.
53. O'Malley S, Adamse M, Heaton RK, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse (1992) 18:131-44. doi:10.3109/00952999208992826.
54. Hoff AL, Riordan H, Morris L, Cestaro V, Wieneke M, Alpert R, et al. Effects of crack cocaine on neurocognitive function. Psychiatry Res (1996) 60:167-76. doi:10.1016/0165-1781(96)02758-8.
55. Gillen RW, Kranzler HR, Bauer LO, Burleson JA, Samarel D, Morrison DJ. Neuropsychologic findings in cocaine-dependent outpatients. Prog Neuropsychopharmacol Biol Psychiatry (1998) 22:1061-76. doi:10.1016/S0278-5846(98)00057-8.
56. Rosselli M, Ardila A, Lubomski M, Murray S, King K. Personality profile and neuropsychological test performance in chronic cocaine-abusers. Int J Neurosci (2001) 110:55-72. doi:10.3109/00207450108994221.
57. Mittenberg W, Motta S. Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol (1993) 8:477-83. doi:10.1016/0887-6177(93)90048-6.
58. Smelson DA, Roy A, Santana S, Engelhart C. Neuropsychological deficits in withdrawn cocaine-dependent males. Am J Drug Alcohol Abuse (1999) 25:377-81. doi:10.1081/ADA-100101867.
59. Goldstein RZ, Leskovjan AC, Hoff AL, Hitzemann R, Bashan F, Khalsa SS, et al. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia (2004) 42:1447-58. doi:10.1016/j.neuropsychologia.2004.04.002.
60. Tucker KA, Potenza MN, Beauvais JE, Browndyke JN, Gottschalk PC, Kosten TR. Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry (2004) 56:527-30. doi:10.1016/j.biopsych.2004.06.031.
61. Kübler A, Murphy K, Garavan H. Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci (2005) 21:1984-92. doi:10.1111/j.1460-9568.2005.04027.x.
62. Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, et al. Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence. Brain Res (2007) 1171:83-92. doi:10.1016/j.brainres.2007.06.102.
63. Hanlon CA, Wesley MJ, Roth AJ, Miller MD, Porrino LJ. Loss of laterality in chronic cocaine users: an fMRI investigation of sensorimotor control. Psychiatry Res (2010) 181:15-23. doi:10.1016/j.pscychresns.2009.07.009.
64. Moeller FG, Steinberg JL, Schmitz JM, Ma L, Liu S, Kjome KL. Working memory fMRI activation in cocaine-dependent subjects: association with treatment response. Psychiatry Res (2010) 181:174-82. doi:10.1016/j.pscychresns.2009.11.003.
65. Volkow ND, Tomasi D, Wang G-J, Fowler JS, Telang F, Goldstein RZ, et al. Reduced metabolism in brain "control networks" following cocaine-cues exposure in female cocaine abusers. PLoS One (2011) 6:e16573. doi:10.1371/journal.pone.0016573.
66. Camchong J, MacDonald AW, Nelson B, Bell C, Mueller BA, Specker S, et al. Frontal hyperconnectivity related to discounting and reversal learning in cocaine subjects. Biol Psychiatry (2011) 69:1117-23. doi:10.1016/j.biopsych.2011.01.008.
67. Barrós-Loscertales A, Garavan H, Bustamante JC, Ventura-Campos N, Llopis JJ, Belloch V, et al. Reduced striatal volume in cocaine-dependent patients. Neuroimage (2011) 56:1021-6. doi:10.1016/j.neuroimage.2011.02.035.
68. Winhusen TM, Somoza EC, Lewis DF, Kropp FB, Horigian VE, Adinoff B. Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response. Drug Alcohol Depend (2013) 127:94-100. doi:10.1016/j.drugalcdep.2012.06.017.
69. Bolla KI, Cadet JL, London ED. The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci (1998) 10:280-9. doi:10.1176/jnp.10.3.280.
70. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition (1994) 50:7-15. doi:10.1016/0010-0277(94)90018-3.
71. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci (2004) 16:456-64. doi:10.1176/jnp.16.4.456.
72. Jones JA, Lim KO, Wozniak JR, Specker S, MacDonald AW III. Context-processing abilities in chronic cocaine users. Psychol Addict Behav (2013) 27:687-95. doi:10.1037/a0032237.
73. Colzato LS, Van den Wildenberg WPM, Hommel B. Impaired inhibitory control in recreational cocaine users. PLoS One (2007) 2:e1143. doi:10.1371/journal.pone.0001143.
74. Moreno-López L, Catena A, Fernández-Serrano MJ, Delgado-Rico E, Stamatakis EA, Pérez-García M, et al. Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Drug Alcohol Depend (2012) 125:208-14. doi:10.1016/j.drugalcdep.2012.02.012.
75. Colzato LS, Huizinga M, Hommel B. Recreational cocaine polydrug use impairs cognitive flexibility but not working memory. Psychopharmacology (2009) 207:225-34. doi:10.1007/s00213-009-1650-0.
76. Colzato LS, Van den Wildenberg WPM, Hommel B. Reduced attentional scope in cocaine polydrug users. PLoS One (2009) 4:e6043. doi:10.1371/journal.pone.0006043.
77. Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM, et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1993) 5:419-27. doi:10.1176/jnp.5.4.419.
78. Robinson JE, Heaton RK, O'Malley SS. Neuropsychological functioning in cocaine abusers with and without alcohol dependence. J Int Soc (1999) 5:10-9.
79. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2006) 81:313-22. doi:10.1016/j.drugalcdep.2005.08.003.
80. Woicik PA, Moeller SJ, Alia-Klein N, Maloney T, Lukasik TM, Yeliosof O, et al. The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology (2009) 34:1112-22. doi:10.1038/npp.2008.60.
81. Kalapatapu RK, Vadhan NP, Rubin E, Bedi G, Cheng WY, Sullivan MA, et al. A pilot study of neurocognitive function in older and younger cocaine abusers and controls. Am J Addict (2011) 20:228-39. doi:10.1111/j.1521-0391.2011.00128.x.
82. Madoz-Gúrpide A, Blasco-Fontecilla H, Baca-García E, Ochoa-Mangado E. Executive dysfunction in chronic cocaine users: an exploratory study. Drug Alcohol Depend (2011) 117:55-8. doi:10.1016/j.drugalcdep.2010.11.030.
83. Soar K, Mason C, Potton A, Dawkins L. Neuropsychological effects associated with recreational cocaine use. Psychopharmacology (2012) 222:633-43. doi:10.1007/s00213-012-2666-4.
84. Vonmoos M, Hulka LM, Preller KH, Jenni D, Baumgartner MR, Stohler R, et al. Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset. Br J Psychiatry (2013) 203:35-43. doi:10.1192/bjp.bp.112.118091.
85. Preller KH, Hulka LM, Vonmoos M, Jenni D, Baumgartner MR, Seifritz E, et al. Impaired emotional empathy and related social network deficits in cocaine users. Addict Biol (2014) 19:452-66. doi:10.1111/adb.12070.
86. Volkow ND, Fowler JS, Wang G-J, Telang F, Logan J, Jayne M, et al. Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage (2010) 49:2536-43. doi:10.1016/j.neuroimage.2009.10.088.
87. Preller KH, Herdener M, Schilbach L, Stämpfli P, Hulka LM, Vonmoos M, et al. Functional changes of the reward system underlie blunted response to social gaze in cocaine users. Proc Natl Acad Sci U S A (2014) 111:2842-7. doi:10.1073/pnas.1317090111.
88. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 14:169-77. doi:10.1002/syn.890140210.
89. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 386:827-30. doi:10.1038/386827a0.
90. Volkow ND, Fowler JS, Wang GJ. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol (1999) 13:337-45. doi:10.1177/026988119901300406.
91. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry (2007) 164:622-9. doi:10.1176/ajp.2007.164.4.622.
92. Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, et al. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am J Psychiatry (2009) 166:1170-7. doi:10.1176/appi.ajp.2009.08121801. Erratum in: Am J Psychiatry (2009) 166:1299.
93. Tomasi D, Volkow ND, Wang R, Carrillo JH, Maloney T, Alia-Klein N, et al. Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers. PLoS One (2010) 5:e10815. doi:10.1371/journal.pone.0010815.
94. Ernst T, Chang L, Oropilla G, Gustavson A, Speck O. Cerebral perfusion abnormalities in abstinent cocaine abusers: a perfusion MRI and SPECT study. Psychiatry Res (2000) 99:63-74. doi:10.1016/S0925-4927(00)00056-1.
95. Herning RI, King DE, Better WE, Cadet JL. Neurovascular deficits in cocaine abusers. Neuropsychopharmacology (1999) 21:110-8. doi:10.1016/S0893-133X(98)00141-9.
96. Verdejo-Garcia A. Social cognition in cocaine addiction. Proc Natl Acad Sci U S A (2014) 111:2406-7. doi:10.1073/pnas.1324287111.
97. Bisagno V, Cadet JL. Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin. Behav Pharmacol (2014) 25:445-57. doi:10.1097/FBP.0000000000000049.
98. Hu Y, Salmeron BJ, Gu H, Stein EA, Yang Y. Impaired functional connectivity within and between frontostriatal circuits and its association with compulsive drug use and trait impulsivity in cocaine addiction. JAMA Psychiatry (2015) 72:584-92. doi:10.1001/jamapsychiatry.2015.1.
99. McHugh MJ, Demers CH, Braud J, Briggs R, Adinoff B, Stein EA. Striatal-insula circuits in cocaine addiction: implications for impulsivity and relapse risk. Am J Drug Alcohol Abuse (2013) 39:424-32. doi:10.3109/00952990.2013.847446.
100. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (2012) 379:55-70. doi:10.1016/S0140-6736(11)61138-0.
101. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict (2000) 9:222-31. doi:10.1080/10550490050148053.
102. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W. Cognitive performance of current methamphetamine and cocaine abusers. J Addictive Dis (2002) 21:61-74. doi:10.1300/J069v21n01_06.
103. Simon SL, Dacey J, Glynn S, Rawson R, Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat (2004) 27:59-66. doi:10.1016/j.jsat.2004.03.011.
104. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology (2002) 26:53-63. doi:10.1016/S0893-133X(01)00334-7.
105. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res (2002) 111:65-74. doi:10.1016/S0165-1781(02)00111-7.
106. Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, et al. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol (2004) 115:194-8. doi:10.1016/S1388-2457(03)00314-6.
107. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev (2007) 17:275-97. doi:10.1007/s11065-007-9031-0.
108. Rendell PG, Mazur M, Henry JD. Prospective memory impairment in former users of methamphetamine. Psychopharmacology (2009) 203:609-16. doi:10.1007/s00213-008-1408-0.
109. Henry JD, Mazur M, Rendell PG. Social-cognitive difficulties in former users of methamphetamine. Br J Clin Psychol (2009) 48:323-7. doi:10.1348/000712609X435742.
110. Henry BL, Minassian A, Perry W. Effect of methamphetamine dependence on everyday functional ability. Addict Behav (2010) 35:593-8. doi:10.1016/j.addbeh.2010.01.013.
111. Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend (2012) 125:146-53. doi:10.1016/j.drugalcdep.2012.04.002.
112. Cattie JE, Woods SP, Iudicello JE, Posada C, Grant I; TMARC Group. Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users. J Neuropsychiatry Clin Neurosci (2012) 24:331-9. doi:10.1176/appi.neuropsych.11080192.
113. Hart CL, Marvin CB, Silver R, Smith EE. Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology (2012) 37:586-608. doi:10.1038/npp.2011.276.
114. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA. Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat (2003) 24:267-77. doi:10.1016/S0740-5472(03)00028-X.
115. Halkitis PN, Shrem MT. Psychological differences between binge and chronic methamphetamine using gay and bisexual men. Addict Behav (2006) 31:549-52. doi:10.1016/j.addbeh.2005.05.040.
116. Semple SJ, Patterson TL, Grant I. A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend (2004) 76:203-12. doi:10.1016/j.drugalcdep.2004.05.003.
117. Semple SJ, Zians J, Grant I, Patterson TL. Impulsivity and methamphetamine use. J Subst Abuse Treat (2005) 29:85-93. doi:10.1016/j.jsat.2005.05.001.
118. Hester R, Lee N, Pennay A, Nielsen S, Ferris J. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. Exp Clin Psychopharmacol (2010) 18:489-97. doi:10.1037/a0021791.
119. Elkashef A, Rawson RA, Smith E, Pearce V, Flammino F, Campbell J, et al. The NIDA methamphetamine clinical trials group: a strategy to increase clinical trials research capacity. Addiction (2007) 102(Suppl 1):107-13. doi:10.1111/j.1360-0443.2007.01779.x.
120. Radfar SR, Rawson RA. Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts. Addict Health (2014) 6:146-54.
121. Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry (2005) 57:967-74. doi:10.1016/j.biopsych.2005.01.039.
122. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry (2005) 58:770-8. doi:10.1016/j.biopsych.2005.04.039.
123. Johanson C-E, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, et al. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (2006) 185:327-38. doi:10.1007/s00213-006-0330-6.
124. Monterosso JR, Ainslie G, Xu J, Cordova X, Domier CP, London ED. Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp (2007) 28:383-93. doi:10.1002/hbm.20281.
125. Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (2006) 188:162-70. doi:10.1007/s00213-006-0494-0.
126. Leland DS, Arce E, Miller DA, Paulus MP. Anterior cingulate cortex and benefit of predictive cueing on response inhibition in stimulant dependent individuals. Biol Psychiatry (2008) 63:184-90.
127. Salo R, Ursu S, Buonocore MH, Leamon MH, Carter C. Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study. Biol Psychiatry (2009) 65:706-9. doi:10.1016/j.biopsych.2008.11.026.
128. Nestor LJ, Ghahremani DG, Monterosso J, London ED. Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res (2011) 194:287-95. doi:10.1016/j.pscychresns.2011.04.010.
129. Payer DE, Lieberman MD, Monterosso JR, Xu J, Fong TW, London ED. Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task. Drug Alcohol Depend (2008) 93:93-102. doi:10.1016/j.drugalcdep.2007.09.009.
130. Hoffman WF, Schwartz DL, Huckans MS, McFarland BH, Meiri G, Stevens AA, et al. Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (2008) 201:183-93. doi:10.1007/s00213-008-1261-1.
131. Brewer JA, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MN. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 64:998-1004. doi:10.1016/j.biopsych.2008.05.024.
132. Kober H, DeVito EE, DeLeone CM, Carroll KM, Potenza MN. Cannabis abstinence during treatment and one-year follow-up: relationship to neural activity in men. Neuropsychopharmacology (2014) 39:2288-98. doi:10.1038/npp.2014.82.
133. Lopez RB, Onyemekwu C, Hart CL, Ochsner KN, Kober H. Boundary conditions of methamphetamine craving. Exp Clin Psychopharmacol (2015) 23:436-44. doi:10.1037/pha0000049.
134. DeVito EE, Worhunsky PD, Carroll KM, Rounsaville BJ, Kober H, Potenza MN. A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend (2012) 122:228-35. doi:10.1016/j.drugalcdep.2011.10.002.
135. Everitt BJ, Robbins TW. Drug addiction: updating actions to habits to compulsions ten years on. Annu Rev Psychol (2016) 67:23-50. doi:10.1146/annurev-psych-122414-033457.
136. Liu X, Matochik JA, Cadet JL, London ED. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology (1998) 18:243-52. doi:10.1016/S0893-133X(97)00143-7.